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ABSTRACT
Background: Lymphatic filariasis is a tropical parasitic disease which has been identified
for elimination by 2020 through mass drugs administration. There is a major problem
in its diagnosis and sensitive surveillance methods for monitoring the disease
elimination programs need to be sought.
Objectives: To establish and evaluate the usefulness of a Polymerase Chain Reaction,
PCR assay employing sputum for diagnosis of Wuchereria bancrofti infections in an
endemic location.
Design: Community based samples collection and a molecular laboratory technologies
study.
Setting: Mpirani, Malindi District and Centre for Biotechnology Research and
Development, Kenya Medical Research Institute.
Subjects: Sputum samples were obtained from 304 willing and consenting participants,
aged between 5 and 73 years resident in Mpirani, Malindi District.
Results: Prevalence of W.  bancrofti infection was found to be 42.8% (130/304) by PCR
assay employing sputum compared with 22.0 % (67/304) and 38.8% (119/304) respectively
for microfilaria counts and ICT.  The sensitivity and specificity of the PCR sputum
assay was 97.5 and 92.4% respectively.  Predictive values were 89.2 and 98.3% for
positive (PPV) and negative (NPV) respectively while accuracy was 94.4%.
Conclusions: The molecular PCR assay using sputum was found to have a great
potential for use in mass diagnosis and in epidemiological studies in patients with W.
bancrofti infections
INTRODUCTION
Lymphatic filariasis is a tropical disease caused by
the parasitic worms Wuchereria bancrofti, Brugia malayi
or B. timori (1).  Ninety per cent of lymphatic filariasis
infections are caused by W. bancrofti.  The life cycle of
these parasites oscillate between humans and the
vector mosquito.  Wuchereria bancrofti has a nocturnal
periodicity, where the microfilariae appear in the
peripheral blood of a patient at night between
10.00pm and 02.00am. During the other times,
however, microfilariae can be found in the lungs,
where the oxygen tension is high.  Although lymphatic
filariasis has low mortality, it is a major cause of
clinical morbidity and disability.  Of the 120 million
infected persons in 80 tropical countries, 44 million
display overt symptoms such as the swelling of limbs
and genitalia (2). World Health Organization (WHO)
initiated a Global Program for Elimination of
Lymphatic Filariasis, (GPELF) by mass treatment of
the infected and those-at-risk, estimated at 1.1 billion
(2).  Research is needed to identify and evaluate
techniques for rapid assessment and mapping of the
disease and to develop mechanisms for surveillance
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and for monitoring the effectiveness of interventions
(3). We report results of an evaluation of the sputum
PCR assay using samples obtained from individuals
living in an endemic locality in coastal Kenya.
MATERIALS AND METHODS
Study population and specimen collection: Sputum and
blood samples were collected from 304 individuals
living in the endemic locality of Mpirani in Malindi
District Kenya (4).  In this study we modified the
method of Abassi et al (5) by using a different set of
primers for detection of W. bancrofti infection in
sputum.  Willing and consenting participants who
had lived in the study area for at least three years and
were above the age of five years were included in the
study.  People who had not lived in the study area for
the last three years were excluded from the study.
Although sputum samples can be collected any time
during the day or night, samples were collected
between 10.00pm and 02.00am together with blood
for microscopy.  This is the time that the microfilariae
of this nocturnal parasite can be found in the blood.
All samples were collected between April and
December, 2004.
Each individual was examined by a qualified
clinician and requested to give sputum and blood.
Approximately 1ml of sputum was collected from each
participant in 0.1M ethylene-diamine tetra acetic acid
(EDTA).  When necessary, sputum was induced by a
deep cough following a brief  jogging or push-up
exercise (5). Blood sample for Immunochromatographic
test (ICT), microfilariae examination and counts
consisted of 1 ml of venous blood collected in 0.1M
EDTA (6, 7).  The sample size 304 was determined using
the formula of Fischer et al (8).
Microfilariae counts and immunochromatographic tests
(ICT): Blood samples were examined for presence of
microfilariae by microscopy using the procedure
recommended by McMahon et al, (1979) (7), where
100μl of patient’s night blood was added to 900μl of
3% Acetic acid and examined under low power in a
microscope, using a special chamber.  All the
microfilariae in the chamber were counted twice and
recorded.
While performing the ICT, 100μl of each blood
sample were processed according to the
manufacturer’s instructions (Binax Inc. USA).
DNA Extraction and PCR amplification: Wuchereria
bancrofti DNA from sputum was extracted as
described by Abbasi et al. (5), with some minor
modifications.  For optimal thermocycling, the DNA
was denatured at 94oC for five minutes, annealing at
54oC for one minute and elongation at 72oC for one
minute.  This was repeated for 35 cycles, before a
further elongation step at 72oC for ten minutes.  The
primer pair used in this study, forward 5’
CGTGATGGCATAAAGTAGCG 3’ and reverse 3’
CCTCACTTACCATAAGACAAC 5’), were
originally designed by Zhong,  et al. (9). They amplified
188bp fragment of W. bancrofti DNA sequence. The
amplification products were separated by
electrophoresis in 1.2% agarose gels against a 200bp
DNA marker. The bands were visualised under UV
light after staining with ethidium bromide and
photographed for permanent record.
RESULTS
Microscopy, microfilariae (MF) counts and ICT: Of the
304 samples of sputum and blood, 126 were obtained
from females and 178 males in the age range 5 - 73
years from five villages of Mpirani (Table 1).
Microfilariae were observed in 22% (67/304) of the
blood samples of the individuals examined.  The
counts ranged from one microfilaria to 866
microfilariae per millilitre of whole blood (Table 2).
There were 237 samples without any microfilariae.
Seven samples had counts ranging from 101 to 866.
When arranged according to age-groups (Table 3),
there was a high prevalence in the age group 51-60
and the lowest in 5-10 group.
Table 1
Distribution of the study population among the five
villages
Village Female Male Total
Garashi 18 21 39
Madzayani 58 93 151
Majehazini 24 31  55
Mbaoni 12 22  34
Sabaki 14 11 25
Total 126 178 304
Table 2
The distribution of microfilaria (MF) counts in the
samples
Microfilaria counts/ml Number of
of blood samples
0 237
1 – 10  41
11 – 100 19
101 – 866 7
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A total of 119 out of 304 samples were found positive
by ICT. This constituted 38.8% of the test samples
with the highest number of positive cases among the
61-73 group who had 62.5% prevalence (Table 4).
Positive cases among the age groups 51-60, 31-40,
and 41-50 years, were 51.9%, 51.6% and 50.0%
respectively.  Age groups 11-20 and 21-30 had a
prevalence of 33.9% and 34.6% respectively.  The
lowest prevalence was found among the 5-10 year
age group who had 22.6%.  Out of the 178 male
population 71 (39.9%) had positive results by ICT.
The highest prevalence was among the 51-60 year
age group, who had 76.9% (10/13) with the lowest
being the 5-10 year age group showing a prevalence
of 21.1% (4/19).
Table 3
Total microfilaria (MF) counts according to age groups
Age group Total number Number positive by Percentage of total
(years) of samples  MF counts  MF counts positive
5-10 31 3 9.7
11-20 121 19 15.7
21-30 52 13 25.0
31-40 31 11 35.5
41-50 26 6 23.1
51-60 27 10 37.0
61-73 16 5 31.3
Total 304 67 22.0
Table 4
 Immunochromatographic test (ICT) results of the total test samples
Age group Total number of Number positive Percentage of
(years) samples by ICT total ICT
5-10 31 7 22.6
11-20 121 41 33.9
21-30 52 18 34.6
31-40 31 16 51.6
41-50 26 13 50.0
51-60 27 14 51.9
61-73 16 10 62.5
Total 304 119 39.1
Polymerase chain reaction PCR assays results: Wuchereria
bancrofti infection detected by PCR sputum assay
was 42.8% (130/304) for all the age groups (Table 5).
Among the age group 61-73 years there was a high
number of positive cases 62.5% (10/16) followed by
the age group 31-40 with 58.1% (18/31), age group
41-50 with 57.7% and age group 51-60 with 51.9%.
Out of 52 samples in the age group 21-30, there were
21 (40.4%) sputum PCR positive samples.  Forty
three samples (35.5%) were sputum PCR positive in
the age group 11-20 years, compared with 29.0% (9/
31) in the age group 5-10 years, which had the lowest
prevalence (Figure 1).
Table 5
Polymerase chain reaction (PCR) assay for sputum in all samples according to age groups
Age group Total number of Number of PCR Percentage of PCR
(years) samples Positive samples  Positive
5-10 31 9 29.0
11-20 121 43 35.5
21-30 52 21 40.4
31-40 31 18 58.1
41-50 26 15 57.7
51-60 27 14 51.9
61-73 16 10 62.5
Total 304 130 42.8
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Seventy three males (41.0%) were sputum PCR positive.
There was high PCR prevalence among the age group
51-60 years with 69.2% (9/13).  The other age groups; 61-
73, 31-40, 41-50, and 21-30 followed with 60.0%, 57.9%,
55.6% and 46.4%, respectively.  The lowest number of
sputum PCR positive cases occurred in 11-20 year age
group with 28.8% (23/80) followed by age group 5-10
years with 31.6%.  Prevalence among females was 66.7%
(4/6) among the 61-73 year age group compared with 5-
10 year group which was the lowest at 25.0% (3/12).
Validation of the PCR assay for sputum: Sensitivity and
specificity for the PCR assay for sputum was performed
as suggested by Greenhalgh (10).  Sensitivity was defined
as the ability of the PCR assays to identify W. bancrofti
DNA in ICT positive samples.  The sensitivity and
specificity of the assay was 97.5 and 92.4%, respectively,
where, the positively identified samples were 116 out of
119 ICT positive samples.
Sensitivity, specificity, predictive values and accuracy:
Positive predictive value (PPV) was defined as the
ability of a positive PCR assay to indicate that the W.
bancrofti DNA is present in a sample.  Consequently, the
Negative predictive value (NPV) was defined as the
ability of a negative PCR assay to indicate    W. bancrofti
DNA was absent in the negative sample.  Using a
formula suggested by Greenhalgh (10), the PPV for PCR
assay for sputum was found to be 89.2% and NPV
98.3%.  Accuracy of the PCR assay was defined as the
proportion of all tests that gave the correct result as
compared with ICT.  The accuracy of PCR assay for
sputum was 94.4%.
Quality control: Gel electrophoresis was repeated thrice
for all samples. Any sample showing a band in two of
the electrophoresis runs was taken to be positive. Further,
thirty samples constituting 9.87% (30/304) of the study
group were selected by picking randomly fifteen positive
and fifteen negative PCR assay and performing 35S dot
blot hybridisation.  Positive results were determined by
appearance of black dots on the photographic film.
There was 100% concordance, indicating that in all
these representative samples all the 15 PCR positive
samples had the specific W. bancrofti DNA, while the
negative samples did not have the specific W. bancrofti
DNA.
DISCUSSION
The present study examined W. bancrofti infections in
Mpirani, Malindi District, Kenya using a PCR assay that
uses sputum and compared the results obtained to ICT
and microfilariae counts.  By using ICT as the standard,
the assay employed in this study was both sensitive and
specific with values around 90%.  The assay had the
highest prevalence (42.8%) compared to ICT (38.8%)
and microscopy (22.0%).   Prevalence increased gently
with age (Figure 1) and although the results did not
show any statistical differences, the males seemed to
Figure 1
Percentage prevalence by sex and age in sputum PCR assay
A=5-10; B=11-20; C=21-30; D=31-40; E=41-50; F=51-60; G=61-73 years
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show a higher prevalence than females.  There were 11
positive samples by PCR, but negative by ICT. All the 11
samples however, had 0 to 10 microfilaria counts per
ml, for which ICT may have missed because it has low
sensitivity (11, 12).  The advantages of the PCR assay
used in this study include high sensitivity,   specificity
and demonstrated a high accuracy value of 94.4%.  This
was coupled with commendable ease of sample
collection.  By using PCR assay that utilise sputum,
there are reduced risks of infection with the blood borne
infectious diseases such as HIV/AIDS and hepatitis
(13) as in deed  a study by Marcus, (14) did demonstrate
that 0.3% of health workers can get infected by HIV/
AIDS if exposed.
Community co-operation is essential in disease
elimination efforts, such as the one underway for
lymphatic filariasis (2). Local people can be shown how
to collect sputum samples and transport them to a central
laboratory thus enhancing the communal participation
and solving most the logistical problems encountered by
visiting medical teams such as access to areas that cannot
otherwise be reached by vehicles (15).
The cost of performing PCR assays remains high
due to various reagents and equipments. Several
researchers have suggested pooling of samples in mass
diagnosis and epidemiological studies.  Abbasi et al.,
were able to pool 14 negative samples with one positive
sample and were able to detect the W. bancrofti DNA (5).
We suggest further studies in this areas, as a way of
reducing cost of performing PCR assays. Pooling of
samples by house hold for instance may, reduce costs of
PCR assays probably by up to 90% as average house
holds in Mpirani has an average of ten persons.  Malhotra
et al., and Weerasooriya, et al., had shown a higher
prevalence of W. bancrofti infection among  children
whose parents were infected (16,17). This would mean
increased chances of patients capture among the
households with W. bancrofti infections in a pooled
sample.  The positive households could then benefit by
treatment of all members as recommended by WHO (2).
Individual patient could be identified by analysing
household members separately in a follow-up.
CONCLUSION
From the outcome of this study, PCR assays that employ
the use of non-invasive sample collection are
recommended for use in mass diagnosis, epidemiology
and surveillance of lymphatic filariasis.  We recommend
that pooling of samples per household and other
methods that could be useful in cost reduction of
performing PCR assays should further be investigated.
The PCR assay utilising sputum can complement
other methods used for epidemiology, mass diagnosis
and surveillance of lymphatic filariasis post elimination
phase.
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